Treatment of Cryptococcal Meningitis in HIV infected patients.

Treatment of patients with Aspergillus species, Candida species and/or Cryptococcus species infections refractory to amphotericin B deoxycholate.

In patients where renal impairment or unacceptable toxicity precludes the use of amphotericin B deoxycholate.

Treatment of visceral leishmaniasis, in immuno-compromised / immunocompetent patients.

Empirical therapy in febrile immunocompromised patients who do not respond to broad-spectrum antibiotics.